Detalhe da pesquisa
1.
Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient-derived osteosarcoma cells and synergizes with cisplatin and talazoparib.
Int J Cancer
; 147(4): 1059-1070, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31782150